Author:
Krämer Anna S.,Adeberg Sebastian,Kronsteiner Dorothea,König Laila,Schunn Fabian,Bozorgmehr Farastuk,Christopoulos Petros,Eichkorn Tanja,Schiele Annabella,Hahnemann Laura,Rieken Stefan,Debus Jürgen,Shafie Rami A. El
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference45 articles.
1. Krebs in Deutschland für 2017/2018;Erdmann;Krebsregister,2021
2. Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group;Lin;Lancet Oncol,2013
3. Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma;Bajard;Lung Cancer,2004
4. Brain metastases in EGFR- and ALK-positive NSCLC: outcomes of central nervous system-penetrant tyrosine kinase inhibitors alone versus in combination with radiation;Thomas;J Thorac Oncol,2022
5. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial;Rosell;Lancet Oncol,2012